Source: Aigenerated

GSI Technology, Inc. (NASDAQ: GSIT) to present at Nasdaq / LD Micro Summit Series in San Francisco

GSI Technology, Inc. (NASDAQ: GSIT) said its Vice President of Sales and Investor Relations, Didier Lasserre, will present at the Nasdaq / LD Micro Summit Series at Nasdaq's San Francisco headquarters on September 9, 2026, followed by a breakout Q&A session.

GSI Technology News: Key Takeaways

  • Didier Lasserre, Vice President of Sales and Investor Relations, is scheduled to participate in the Nasdaq / LD Micro Summit Series on September 9, 2026.
  • GSI Technology's presentation is set for 10:20 a.m. Pacific time, with a breakout Q&A session to follow.
  • The event will be held at Nasdaq Headquarters, 350 Mission St., 11th Floor, San Francisco, California.
  • The summit format includes a 15-minute company overview to institutional investors and a 15-minute breakout Q&A session immediately afterward.
  • The company said investors interested in meeting with GSI Technology should contact their LD Micro representative or GSI Technology investor relations.

What happened?

GSI Technology announced it will participate in the Nasdaq / LD Micro Summit Series, with Didier Lasserre delivering the company's scheduled presentation and taking part in a breakout Q&A session. The company provided the event logistics, including the date, time, and venue in San Francisco.

Why this matters for investors

Conference participation can increase visibility with institutional investors and provide an opportunity for investors to ask management questions in a structured Q&A setting. The announcement also signals a near-term investor relations milestone (September 9, 2026) when the company expects to provide an overview of its business.

The original press release is available on stockhouse.com

More From The Market Online

Copper Lake to switch to semi-annual reporting

Copper Lake Resources Ltd. (TSXV: CPL) moves to semi-annual financial reporting under Canadian venture issuer exemption Copper Lake Resources News: Key Takeaways Copper Lake…

Scribe starts Phase 1 trial for cholesterol drug STX-1150

Scribe Therapeutics Inc. (NASDAQ: SCTX) reports Q2 2026 results, starts Phase 1 for STX-1150, and outlines post-IPO cash runway Scribe Therapeutics Inc. (NASDAQ: SCTX)…

Superior Group to attend two September investor events

Superior Group of Companies, Inc. (NASDAQ: SGC) to present at two September virtual investor conferences Superior Group of Companies News: Key Takeaways Superior Group…

Attovia flags ATTO-1310 itch data, Phase 1b readout Q4

Attovia Therapeutics, Inc. (NASDAQ: ATTO) reports Q2 2026 results, highlights ATTO-1310 Phase 1b progress and post-IPO cash runway Attovia Therapeutics, Inc. (NASDAQ: ATTO) reported…